Literature DB >> 28844868

Complexity of the Wnt/β‑catenin pathway: Searching for an activation model.

Giovane G Tortelote1, Renata R Reis2, Fabio de Almeida Mendes2, Jose Garcia Abreu3.   

Abstract

Wnt signaling refers to a conserved signaling pathway, widely studied due to its roles in cellular communication, cell fate decisions, development and cancer. However, the exact mechanism underlying inhibition of the GSK phosphorylation towards β-catenin and activation of the pathway after biding of Wnt ligand to its cognate receptors at the plasma membrane remains unclear. Wnt target genes are widely spread over several animal phyla. They participate in a plethora of functions during the development of an organism, from axial specification, gastrulation and organogenesis all the way to regeneration and repair in adults. Temporal and spatial oncogenetic re-activation of Wnt signaling almost certainly leads to cancer. Wnt signaling components have been extensively studied as possible targets in anti-cancer therapies. In this review we will discuss one of the most intriguing questions in this field, that is how β-catenin, a major component in this pathway, escapes the destruction complex, gets stabilized in the cytosol and it is translocated to the nucleus where it acts as a co-transcription factor. Four major models have evolved during the past 20years. We dissected each of them along with current views and future perspectives on this pathway. This review will focus on the molecular mechanisms by which Wnt proteins modulate β-catenin cytoplasmic levels and the relevance of this pathway for the development and cancer.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Axin; Cancer; Development; LRP5/6; Stem cell; Wnt; β‑catenin

Mesh:

Substances:

Year:  2017        PMID: 28844868     DOI: 10.1016/j.cellsig.2017.08.008

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  28 in total

Review 1.  Dickkopf1: An immunomodulatory ligand and Wnt antagonist in pathological inflammation.

Authors:  Wook-Jin Chae; Alfred L M Bothwell
Journal:  Differentiation       Date:  2019-06-12       Impact factor: 3.880

2.  The Synthetic Small Molecule FL3 Combats Intestinal Tumorigenesis via Axin1-Mediated Inhibition of Wnt/β-Catenin Signaling.

Authors:  Dakota N Jackson; Kibrom M Alula; Yaritza Delgado-Deida; Redouane Tabti; Kevin Turner; Xuan Wang; K Venuprasad; Rhonda F Souza; Laurent Désaubry; Arianne L Theiss
Journal:  Cancer Res       Date:  2020-07-14       Impact factor: 12.701

Review 3.  Wnt/Beta-Catenin Signaling Regulation and a Role for Biomolecular Condensates.

Authors:  Kristina N Schaefer; Mark Peifer
Journal:  Dev Cell       Date:  2019-02-25       Impact factor: 12.270

4.  Zooming in on the WNT/CTNNB1 Destruction Complex: Functional Mechanistic Details with Implications for Therapeutic Targeting.

Authors:  Saskia Madelon Ada de Man; Renée van Amerongen
Journal:  Handb Exp Pharmacol       Date:  2021

Review 5.  Controlling the master-upstream regulation of the tumor suppressor LKB1.

Authors:  Lars Kullmann; Michael P Krahn
Journal:  Oncogene       Date:  2018-03-15       Impact factor: 9.867

6.  Thyroid Hormone Promotes β-Catenin Activation and Cell Proliferation in Colorectal Cancer.

Authors:  Yee-Shin Lee; Yu-Tang Chin; Ya-Jung Shih; André Wendindondé Nana; Yi-Ru Chen; Han-Chung Wu; Yu-Chen S H Yang; Hung-Yun Lin; Paul J Davis
Journal:  Horm Cancer       Date:  2018-01-29       Impact factor: 3.869

7.  m6A RNA methylation impacts fate choices during skin morphogenesis.

Authors:  Thomas Carroll; Irina Matos; Linghe Xi; Ji-Dung Luo; Lisa Polak; H Amalia Pasolli; Samie R Jaffrey; Elaine Fuchs
Journal:  Elife       Date:  2020-08-26       Impact factor: 8.140

Review 8.  Metabolic programming of nephron progenitor cell fate.

Authors:  Giovane G Tortelote; Mariel Colón-Leyva; Zubaida Saifudeen
Journal:  Pediatr Nephrol       Date:  2020-10-21       Impact factor: 3.714

9.  MicroRNA-22-3p targeted regulating transcription factor 7-like 2 (TCF7L2) constrains the Wnt/β-catenin pathway and malignant behavior in osteosarcoma.

Authors:  YuanLiang Xue; Ya Guo; Ning Liu; XiangQi Meng
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

10.  Suppression of Membranous LRP5 Recycling, Wnt/β-Catenin Signaling, and Colon Carcinogenesis by 15-LOX-1 Peroxidation of Linoleic Acid in PI3P.

Authors:  Fuyao Liu; Xiangsheng Zuo; Yi Liu; Yasunori Deguchi; Micheline J Moussalli; Weidong Chen; Peiying Yang; Bo Wei; Lin Tan; Philip L Lorenzi; Shen Gao; Jonathan C Jaoude; Amir Mehdizadeh; Lovie Ann Valentin; Daoyan Wei; Imad Shureiqi
Journal:  Cell Rep       Date:  2020-08-18       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.